TBD | The Rise of Off-Brand Ozempic
What Next | Daily News and Analysis
00:00
Navigating Telehealth and Prescription Medications
This chapter examines the evolving landscape of telehealth services providing off-brand GLP-1 medications, contrasting the legitimate providers with gray market sellers. It also discusses the implications of easy online access to prescriptions, ethical concerns surrounding patient disclosure, and the regulatory scrutiny faced by compounding pharmacies amid safety and quality debates.
Transcript
Play full episode
